Hundreds of new RNA viruses are discovered every year, but every discovery brings an unexpected challenge: what should the new virus be called? While some names describe where a virus was found or which species it infects, others draw inspiration from mythology, language, biology and even heavy metal music.
Among the viruses officially recorded in international genetic sequence databases are Galbūt ("Maybe"), Ūsinis, Barstukas, Pikulas and Patulas, all named by Lithuanian virologist Dr Gytis
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
H1 and Novo Nordisk Partner to Advance AI-Driven Clinical Development
What You Should Know
Healthcare data and AI platform H1 announced a strategic partnership with global pharmaceutical leader Novo Nordisk to modernize clinical trial development.Under the agreement, H1 will acquire rights to further advance StudyHub, Novo Nordisk's proprietary digital and AI-enabled platform for clinical trial execution.The collaboration combines H1's global Doctor Graph and AI-ready datasets with Novo Nordisk’s clinical trial operations to optimize protocol design, site
Read More
Inocras Closes $31M for Whole-Genome Bioinformatics Platform
What You Should Know
San Diego-based bioinformatics company Inocras Inc. closed an oversubscribed $31M Series B-3 financing round, bringing its total capital raised to approximately $100M.The funding round was supported by strategic investors NDS Corporation and Aimed Bio Inc., alongside new investors IMM Investment, Korea Investment & Securities, LoftyRock Investment, DT& Investment, Woori Investment & Securities, and Shinhan Securities.Proceeds will fund the U.S. expansion of
Read More
Pharma Is Deploying AI Faster Than It Can Understand Its Risk
A year ago, integrating AI-powered clinical workflow tools could take months of review and planning across disparate teams within a pharmaceutical company's IT, security, and risk teams. Today, with the proliferation of tools that have less than a month of onboarding and can provide immediate value to clinical teams, the way risk is approached has changed. For better or worse, AI capabilities are outpacing the security programs meant to govern them, and many companies are simply assuming risk
Read More
Healing Without Drugs: A Promising Future for Alzheimer’s Patients
Of the medical diagnoses that cause anxiety, sorrow, and despair for patients and their loved ones, Alzheimer’s is near the top of the list. An incurable condition that slowly robs people of memory, identity, and independence, Alzheimer’s puts immense financial and emotional burdens on families.
That may be changing for more than 7 million Americans living with the disease, and the hundreds of thousands more who are newly diagnosed each year. A new wave of scientific and technological
Read More
If Everyone Claims to Accelerate Clinical Trials, Why Are We Still Falling Behind?
The clinical trials industry has never had more tools, data, or innovation aimed at accelerating timelines. In fact, if you walk the floor of any industry event you’ll see “acceleration” everywhere. It’s in the messaging, the booths, the product demos, and the promises. From AI-driven feasibility models to precision targeting, digital recruitment strategies, and decentralized trial technologies, the system appears more advanced and faster than ever. Yet approximately 80–85% of clinical trials
Read More
Medidata Launches Medidata Plus AI Layer to Standardize Clinical Trial Data and Workflows
What You Should Know
Medidata, a Dassault Systèmes brand, has launched Medidata Plus, an embedded clinical artificial intelligence layer designed to unlock scalable AI capabilities across the entire Medidata Platform.While 92% of life sciences decision-makers plan to increase AI spend, only 29% report AI meets their expectations. Medidata Plus eliminates disparate point solutions, providing a predictable, standardized data layer across the trial lifecycle.Automates Electronic Data Capture
Read More
Cheiron Raises $8M to Launch AI-Native the Operating System for Drug Programs
What You Should Know
AI-native life sciences platform Cheiron has secured $8M in seed funding led by Menlo Ventures, with Venky Ganesan joining the board.Strategic backers include Moderna co-founder Robert Langer, former Pfizer CMO Freda Lewis-Hall, Chai Discovery CEO Josh Meier, former Starbucks CEO Laxman Narasimhan, and former Apple AI chief John Giannandrea.Cheiron is designed to replace fragmented spreadsheets, papers, and filings by representing an entire drug development lifecycle as a
Read More
Flatiron Health Expands Global Oncology Network via First Partnership in Scotland with NHSGGC
What You Should Know
Flatiron Health UK has partnered with NHS Greater Glasgow and Clyde (NHSGGC), Scotland's largest health board, establishing Flatiron's first research footprint in the Scottish healthcare system.The NHSGGC collaboration contributes to a nearly 70% expansion of Flatiron's international oncology network over the past year, which now spans more than 50 leading sites across the UK, Germany, and Japan.Flatiron's global oncology dataset is constructed from over six million
Read More
Bluesight Partners with Pfizer to Integrate SmartDose™ Source-Tagged Medications into KitCheck
What You Should Know
Hospital intelligence leader Bluesight has partnered with Pfizer Global Hospital & Biosimilars to integrate Pfizer’s SmartDose™ RFID-enabled medications into the KitCheck inventory management platform.The partnership shifts RFID tagging upstream to the point of manufacture, allowing hospital pharmacies to procure pre-tagged, pre-encoded, and pre-associated medications right out of the box.SmartDose™ marks an industry first by utilizing automated readback verification
Read More
